Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Brain Cancer. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

Available until 6/1/2024

Welcome to PracticeUpdate! We hope you are enjoying access to a selection of our top-read and most recent articles. Please register today for a free account and gain full access to all of our expert-selected content.

Already Have An Account? Log in Now


Journal Scan / Research · December 21, 2022

Determining VTE Risk in Patients With Adult-Type Diffuse Glioma





This abstract is available on the publisher's site.

Access this abstract now  

Additional Info

Disclosure statements are available on the authors' profiles:

Determining venous thromboembolism risk in patients with adult-type diffuse glioma
Blood 2022 Nov 18;[EPub Ahead of Print], KB Burdett, D Unruh, M Drumm, A Steffens, JB Lamano, J Judkins, M Schwartz, R Javier, C Amidei, ES Lipp, KB Peters, A Lai, BSC Eldred, AB Heimberger, K McCortney, DM Scholtens, C Horbinski

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading